Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment. (2019)
Attributed to:
EPSRC Centre for New Mathematical Sciences Capabilities for Healthcare Technologies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0488-4
PubMed Identifier: 31182766
Publication URI: http://europepmc.org/abstract/MED/31182766
Type: Journal Article/Review
Volume: 121
Parent Publication: British journal of cancer
Issue: 2
ISSN: 0007-0920